Clinical trials recruiting for Essential Hypertension

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
  NCT06441630 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Childhood-Onset Essential Hypertension Natural History Study
  NCT06778239 · Phase: Not specified · Ages: 2 Years to 99 Years · Sex: All (male and female) · 1 location
• Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension
  NCT05845905 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 85 Years · Sex: All (male and female) · 1 location
• Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension
  NCT07803835 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
  NCT06643819 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN（FIM）
  NCT06877234 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension
  NCT03945305 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers
  NCT07282145 · Phase: Phase 1 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension
  NCT05880056 · Phase: Phase 4 · Ages: 21 Years to 65 Years · Sex: All (male and female) · 1 location
• Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study
  NCT06568640 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension
  NCT07051811 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 18 locations

Related conditions

Trials recruiting for Essential Hypertension often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Essential Hypertension trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.